New York Life Investment Management’s Unitil UTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,030
Closed -$368K 1302
2024
Q1
$368K Buy
7,030
+927
+15% +$46.7K ﹤0.01% 1029
2023
Q4
$321K Sell
6,103
-139
-2% -$6.73K ﹤0.01% 1178
2023
Q3
$267K Sell
6,242
-983
-14% -$48.1K ﹤0.01% 1223
2023
Q2
$366K Sell
7,225
-1,197
-14% -$66.4K ﹤0.01% 1117
2023
Q1
$480K Sell
8,422
-2,951
-26% -$158K 0.01% 886
2022
Q4
$584K Buy
11,373
+1,220
+12% +$62.1K 0.01% 788
2022
Q3
$472K Buy
10,153
+804
+9% +$43.5K 0.01% 792
2022
Q2
$549K Buy
+9,349
New +$505K 0.01% 685

Other funds holding UTL

New York Life Investment Management's UTL Position: Q2 2024 in Review

New York Life Investment Management sold out of Unitil (UTL) in Q2 2024, closing a stake of 7,030 shares — an estimated $368K sold.

New York Life Investment Management first reported a position in UTL in Q2 2022 and held it in 8 quarters. The position peaked at $584K in Q4 2022. 200 funds tracked by Wall St. Rank hold UTL as of Q2 2024.

  • New York Life Investment Management reported no remaining Unitil position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 7,030 Unitil shares in Q2 2024, an estimated $368K.
  • New York Life Investment Management first reported a position in Unitil in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Unitil position peaked at $584K in Q4 2022.
  • 200 funds tracked by Wall St. Rank held Unitil as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.